NCT07061691 · Shirley Ryan AbilityLab
WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity
What this study is about
This study is to develop, test, and optimize a soft hip wearable robot for individuals who have experience a stroke.
View original scientific description
This study is to develop, test, and optimize a soft hip wearable robot for individuals who have experience a stroke.
Interventions
DEVICE
WIM Robotic Exoskeleton
Wearable hip-powered exoskeleton
Primary outcome measures
6-minute walk test
Time frame: Baseline (Single-session)
Primary outcome for Optimization aim of study.
Metabolic Cost
Time frame: Baseline (single session)
Primary outcome for Optimization aim of study. Data collected using Cosmed K5 Metabolic Unit
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- \- Be at least 6 months post-stroke, have a diagnosis of Parkinson's, have a diagnosis of multiple sclerosis, or an adult older than 65 with no known neurological diagnoses. For the Optimization Aim of the study, Participants may also be healthy individuals with no known impairments.
- Age: 18-89 years of age
- For stroke, Parkinson's, multiple sclerosis, or older adult participants, must have adequate cognitive function (MMSE score \>17)
- Ability to walk at least 10 meters with maximum of 1 person assist
- Able to safely fit into the WIM exosuit, which is confirmed via an in-person fitting..
Exclusion criteria
- \- \<90 days post major orthopedic surgery (i.e. hip, knee, and/or ankle joint replacement.)
- \< 6 months post CABG or cardiac valve procedure
- Any skin irritations / conditions that may preclude a participant from tolerating the use of the exosuit.
- Severe osteoporosis, defined as osteoporosis that has been diagnosed and a participant's doctor has recommended pharmacologic treatment, or there is both a history of osteoporosis and a history of fractures.
- Serious cardiac conditions, such as hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living.
- Uncontrolled hypertension (resting systolic blood pressure greater than or equal to 150, or resting diastolic pressure greater than or equal to 90.) If a participant demonstrates a BP greater than these values, then the participant will sit quietly for 5 mins, and then be re-checked. If the BP values remain over those thresholds, then the participant will be excluded. Individuals in such situations may return to be re-screened for participation after they follow up with their physician and the hypertension is better controlled.
- Lower extremity fracture, either currently or within the past 6 months.
- Modified Ashworth Spasticity (MAS) scores of ≥ 3 in hip flexors or extensors, if the participant is post-stroke or multiple sclerosis.
- Pre-existing neurological disorders such as amyotrophic lateral sclerosis (ALS), dementia
- History of major head trauma, lower extremity amputation, non-healing ulcers of a lower extremity, ongoing active infections, legal blindness, or a history of significant psychiatric illness.
Where
- Chicago, Illinois
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 29, 2025 · Source of record for eligibility and locations